Clinical Trial Update: Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating how surgical resection influences circulating tumor DNA in patients with resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Resectable Pancreatic Cancer | NA | Status: COMPLETED